Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate
CAS : 2888-09-7
Ref. 3D-CAA88809
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate
Description :
Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate (HMN) is a potent anticancer agent that has been shown to be cytotoxic in a variety of cancer cell lines. It inhibits the activity of topoisomerase II, leading to DNA damage and apoptosis. HMN also induces the release of cytochrome c from mitochondria, which activates caspases and initiates apoptosis. HMN has been studied for its cytotoxic effects on colorectal cancer cells. HMN was found to inhibit the growth of colorectal cancer cell lines with an IC50 value of 0.6 microM, but not normal colon cells. This suggests that HMN may be used as a chemotherapeutic agent against colorectal cancer.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
227.17 g/mol
Formule :
C9H9NO6
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
